The editorial board and contributors to HEPP News include national and regional correctional professionals, selected on the basis of their experience with HIV and hepatitis care in the correctional setting.
Faculty Disclosure
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the faculty for this activity have been asked to complete Conflict of Interest Disclosure forms. Disclosures are listed at the end of articles. All of the individual medications discussed in this newsletter are approved for treatment of HIV and hepatitis unless otherwise indicated. For the treatment of HIV and hepatitis infection, many physicians opt to use combination antiretroviral therapy which is not addressed by the FDA.
HEPP News is grateful for the support of the following companies through unrestricted educational grants:
Major Support: Agouron Pharmaceuticals, Abbott Laboratories and Roche Pharmaceuticals
Sustaining: Boehringer-Ingelheim/Roxane Laboratories and Schering-Plough